Discontinuing tyrosine kinase inhibitor maintenance after extended complete molecular response should only be attempted as part of a clinical trial, the researchers say.

To know 8-year-old Brielle Ambabo is to love her. Her silly personality, upbeat attitude and countless jokes are sure to ...

Imagine one day of your life, completely normal. And the next – your entire life is dedicated to your child’s survival.

The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

A new nonprofit organization is looking to help people adopt and support cats affected by feline immunodeficiency and feline ...

This nonrandomised study, conducted between 2017 and 2021, involved 201 patients across 43 centres, including both academic ...